|
|
H2022/CTD9931/21816
|
DEXATAS 5% SOLUTION FOR INFUSION
|
GLUCOSE MONOHYDRATE
|
TASA PHARMA LIMITED
|
Registered
|
Details →
|
|
|
17949
|
SABAX DIANEAL 1.5 SOLUTION
|
GLUCOSE MONOHYDRATE 15GM SODIUM CHLORIDE 5.6GM SODIUM LACTATE 5.0GM CALCIUM CHLORIDE DIHYDRATE 257MG & MAGNESIUM CHLORIDE HEXAHYDRATE 150MG
|
ADCOCK INGRAM E.A. LTD
|
Registered
|
Details →
|
|
|
17950
|
SABAX DIANEAL 2.5 SOLUTION
|
GLUCOSE MONOHYDRATE 25GM SODIUM CHLORIDE 5.38GM SODIUM LACTATE 4.48GM CALCIUM CHLORIDE DIHYDRATE 257MG & MAGNESIUM CHLORIDE HEXAHYDRATE 50.8MG
|
ADCOCK INGRAM E.A. LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10402/23353
|
TASALINE 0.9% D5 SOLUTION FOR INFUSION
|
GLUCOSE MONOHYDRATE + SODIUM CHLORIDE
|
TASA PHARMA LIMITED
|
Registered
|
Details →
|
|
|
17951
|
SABAX DIANEAL 4.25 SOLUTION
|
GLUCOSE MONOHYDRATE 42.5GM SODIUM CHLORIDE 5.67GM SODIUM LACTATE 3.92GM CALCIUM CHLORIDE DIHYDRATE 0.257GM & MAGNESIUM CHLORIDE HEXAHYDRATE 0.152GM
|
ADCOCK INGRAM E.A. LTD
|
Registered
|
Details →
|
|
|
H2024/CTD10432/23354
|
TASALINE 0.45% D5 SOLUTION FOR INFUSION
|
GLUCOSE MONOHYDRATE + SODIUM CHLORIDE
|
TASA PHARMA LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD9932/22011
|
DEXATAS 50 % CONCENTRATE FOR SOLUTION FOR INFUSION
|
GLUCOSE MONOHYDRATE
|
TASA PHARMA LIMITED
|
Registered
|
Details →
|
|
|
-
|
Pabrinex Intravenous High Potency Solution for…
|
Glucose monohydrate, Nicotinamide, Ascorbic Acid,…
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2015/CTD2680/354
|
KABIVEN
|
1000 ML OF MIXED SOLUTION CONTAINS: GLUCOSE MONOHYDRATE (CORRESP. TO GLUCOSE ANHYDROUS), PURIFIED SOYBEAN OIL, L-ALANINE, L-ARGININE, L-ASPARTIC ACID, L-GLUTAMIC ACID, GLYCINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSIN
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
14767, H2005/184
|
KABIVEN PERIPHERAL
|
1000 ML OF MIXED SOLUTION CONTAINS: GLUCOSE MONOHYDRATE (CORRESP. TO GLUCOSE ANHYD.), PURIFIED SOYBEAN OIL, L-ALANINE, L-ARGININE L-ASPARTIC ACID, L-GLUTAMIC ACID, GLYCINE, L-HI...
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
9905
|
PABRINEX INTRAVENOUS HIGH POTENCY SOLUTION FOR INJECTION
|
GLUCOSE MONOHYDRATE, NICOTINAMIDE, ASCORBIC ACID, RIBOFLAVIN SODIUM PHOSPHATE, THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE
|
PHILLIPS THERAPEUTICS LIMITED
|
Withdrawn
|
Details →
|
|
|
H2024/CTD10596/24006
|
TASRINEX IVHP CONCENTRATE FOR SOLUTION FOR INFUSION
|
THIAMINE HCL + RIBOFLAVIN SODIUM PHOSPHATE + PYRIDOXINE HCL + ASCORBIC ACID + NICOTINAMIDE + GLUCOSE MONOHYDRATE
|
TASA PHARMA LIMITED
|
Registered
|
Details →
|